APO Research

APO RESEARCH · REPORT

High-Throughput Sequencing Technology

Selected research

Market Outlook & Growth Opportunities

Global High-Throughput Sequencing Technology Market Outlook and Growth Opportunities 2026

Market perspective

The global High-Throughput Sequencing Technology market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for High-Throughput Sequencing Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for High-Throughput Sequencing Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for High-Throughput Sequencing Technology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the High-Throughput Sequencing Technology market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the High-Throughput Sequencing Technology market include Eurofins Scientific, Natera, BGI, Illumina, Roche, LabCorp, Berry Genomics, Brooks Life Sciences and Macrogen, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global High-Throughput Sequencing Technology market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of High-Throughput Sequencing Technology and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents High-Throughput Sequencing Technology revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global High-Throughput Sequencing Technology market.

High-Throughput Sequencing Technology Segment by Company

Eurofins Scientific

Natera

BGI

Illumina

Roche

LabCorp

Berry Genomics

Brooks Life Sciences

Macrogen

Personalis

Novogene

Genotypic Technology

Dna Link

High-Throughput Sequencing Technology Segment by Type

Targeted Sequencing

Whole Exome Sequencing

Whole Genome Sequencing

High-Throughput Sequencing Technology Segment by Application

Hospitals and Clinics

Biopharma Companies

Academic & Research Organizations

Others

High-Throughput Sequencing Technology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global High-Throughput Sequencing Technology status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the High-Throughput Sequencing Technology key companies, revenue, market share, and recent developments.

3. To split the High-Throughput Sequencing Technology breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions High-Throughput Sequencing Technology market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify High-Throughput Sequencing Technology significant trends, drivers, influence factors in global and regions.

6. To analyze High-Throughput Sequencing Technology competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global High-Throughput Sequencing Technology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of High-Throughput Sequencing Technology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of High-Throughput Sequencing Technology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global High-Throughput Sequencing Technology industry.

Chapter 3: Detailed analysis of High-Throughput Sequencing Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of High-Throughput Sequencing Technology in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of High-Throughput Sequencing Technology in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. High-Throughput Sequencing Technology Industry Trends Table 2. High-Throughput Sequencing Technology Industry Drivers Table 3. High-Throughput Sequencing Technology Industry Opportunities and Challenges Table 4. High-Throughput Sequencing Technology Industry Restraints Table 5. Global High-Throughput Sequencing Technology Revenue by Company (US$ Million) & (2021-2026) Table 6. Global High-Throughput Sequencing Technology Revenue Share by Company (2021-2026) Table 7. Global High-Throughput Sequencing Technology Company Ranking, (2024-2026) & (US$ Million) Table 8. Global High-Throughput Sequencing Technology Key Company Manufacturing Base & Headquarters Table 9. Global High-Throughput Sequencing Technology Company, Product Type & Application Table 10. Global High-Throughput Sequencing Technology Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global High-Throughput Sequencing Technology by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Targeted Sequencing Table 15. Significant Companies of Whole Exome Sequencing Table 16. Significant Companies of Whole Genome Sequencing Table 17. Global High-Throughput Sequencing Technology Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global High-Throughput Sequencing Technology Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global High-Throughput Sequencing Technology Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global High-Throughput Sequencing Technology Sales Value Share by Type (2021-2026) Table 21. Global High-Throughput Sequencing Technology Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals and Clinics Table 23. Significant Companies of Biopharma Companies Table 24. Significant Companies of Academic & Research Organizations Table 25. Significant Companies of Others Table 26. Global High-Throughput Sequencing Technology Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global High-Throughput Sequencing Technology Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global High-Throughput Sequencing Technology Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global High-Throughput Sequencing Technology Sales Value Share by Application (2021-2026) Table 30. Global High-Throughput Sequencing Technology Sales Value Share by Application (2027-2032) Table 31. Global High-Throughput Sequencing Technology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global High-Throughput Sequencing Technology Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global High-Throughput Sequencing Technology Sales Value Share by Region (2021-2026) Table 34. Global High-Throughput Sequencing Technology Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global High-Throughput Sequencing Technology Sales Value Share by Region (2027-2032) Table 36. Global High-Throughput Sequencing Technology Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global High-Throughput Sequencing Technology Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global High-Throughput Sequencing Technology Sales Value Market Share by Country (2021-2026) Table 39. Global High-Throughput Sequencing Technology Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global High-Throughput Sequencing Technology Sales Value Market Share by Country (2027-2032) Table 41. Eurofins Scientific Company Information Table 42. Eurofins Scientific Business Overview Table 43. Eurofins Scientific High-Throughput Sequencing Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Eurofins Scientific High-Throughput Sequencing Technology Product Portfolio Table 45. Eurofins Scientific Recent Development Table 46. Natera Company Information Table 47. Natera Business Overview Table 48. Natera High-Throughput Sequencing Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Natera High-Throughput Sequencing Technology Product Portfolio Table 50. Natera Recent Development Table 51. BGI Company Information Table 52. BGI Business Overview Table 53. BGI High-Throughput Sequencing Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. BGI High-Throughput Sequencing Technology Product Portfolio Table 55. BGI Recent Development Table 56. Illumina Company Information Table 57. Illumina Business Overview Table 58. Illumina High-Throughput Sequencing Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Illumina High-Throughput Sequencing Technology Product Portfolio Table 60. Illumina Recent Development Table 61. Roche Company Information Table 62. Roche Business Overview Table 63. Roche High-Throughput Sequencing Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Roche High-Throughput Sequencing Technology Product Portfolio Table 65. Roche Recent Development Table 66. LabCorp Company Information Table 67. LabCorp Business Overview Table 68. LabCorp High-Throughput Sequencing Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. LabCorp High-Throughput Sequencing Technology Product Portfolio Table 70. LabCorp Recent Development Table 71. Berry Genomics Company Information Table 72. Berry Genomics Business Overview Table 73. Berry Genomics High-Throughput Sequencing Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Berry Genomics High-Throughput Sequencing Technology Product Portfolio Table 75. Berry Genomics Recent Development Table 76. Brooks Life Sciences Company Information Table 77. Brooks Life Sciences Business Overview Table 78. Brooks Life Sciences High-Throughput Sequencing Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Brooks Life Sciences High-Throughput Sequencing Technology Product Portfolio Table 80. Brooks Life Sciences Recent Development Table 81. Macrogen Company Information Table 82. Macrogen Business Overview Table 83. Macrogen High-Throughput Sequencing Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Macrogen High-Throughput Sequencing Technology Product Portfolio Table 85. Macrogen Recent Development Table 86. Personalis Company Information Table 87. Personalis Business Overview Table 88. Personalis High-Throughput Sequencing Technology Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Personalis High-Throughput Sequencing Technology Product Portfolio Table 90. Personalis Recent Development Table 91. Novogene Company Information Table 92. Novogene Business Overview Table 93. Novogene High-Throughput Sequencing Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Novogene High-Throughput Sequencing Technology Product Portfolio Table 95. Novogene Recent Development Table 96. Genotypic Technology Company Information Table 97. Genotypic Technology Business Overview Table 98. Genotypic Technology High-Throughput Sequencing Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Genotypic Technology High-Throughput Sequencing Technology Product Portfolio Table 100. Genotypic Technology Recent Development Table 101. Dna Link Company Information Table 102. Dna Link Business Overview Table 103. Dna Link High-Throughput Sequencing Technology Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Dna Link High-Throughput Sequencing Technology Product Portfolio Table 105. Dna Link Recent Development Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. High-Throughput Sequencing Technology Product Image Figure 2. Global High-Throughput Sequencing Technology Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global High-Throughput Sequencing Technology Market Size (2021-2032) & (US$ Million) Figure 4. Global High-Throughput Sequencing Technology Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Targeted Sequencing Image Figure 8. Whole Exome Sequencing Image Figure 9. Whole Genome Sequencing Image Figure 10. Global High-Throughput Sequencing Technology Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global High-Throughput Sequencing Technology Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global High-Throughput Sequencing Technology Sales Value Share by Type (2021-2032) Figure 13. Hospitals and Clinics Image Figure 14. Biopharma Companies Image Figure 15. Academic & Research Organizations Image Figure 16. Others Image Figure 17. Global High-Throughput Sequencing Technology Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global High-Throughput Sequencing Technology Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global High-Throughput Sequencing Technology Sales Value Share by Application (2021-2032) Figure 20. Global High-Throughput Sequencing Technology Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global High-Throughput Sequencing Technology Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America High-Throughput Sequencing Technology Sales Value (2021-2032) & (US$ Million) Figure 23. North America High-Throughput Sequencing Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe High-Throughput Sequencing Technology Sales Value (2021-2032) & (US$ Million) Figure 25. Europe High-Throughput Sequencing Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific High-Throughput Sequencing Technology Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific High-Throughput Sequencing Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America High-Throughput Sequencing Technology Sales Value (2021-2032) & (US$ Million) Figure 29. South America High-Throughput Sequencing Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa High-Throughput Sequencing Technology Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa High-Throughput Sequencing Technology Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Targeted Sequencing
  • Whole Exome Sequencing
  • Whole Genome Sequencing
Applications
  • Hospitals and Clinics
  • Biopharma Companies
  • Academic & Research Organizations
  • Others
Companies covered
  • Eurofins Scientific
  • Natera
  • BGI
  • Illumina
  • Roche
  • LabCorp
  • Berry Genomics
  • Brooks Life Sciences
  • Macrogen
  • Personalis
  • Novogene
  • Genotypic Technology
  • Dna Link

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global High-Throughput Sequencing Technology Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global High-Throughput Sequencing Technology Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 High-Throughput Sequencing Technology Market Dynamics
  1. 2.1 High-Throughput Sequencing Technology Industry Trends
  2. 2.2 High-Throughput Sequencing Technology Industry Drivers
  3. 2.3 High-Throughput Sequencing Technology Industry Opportunities and Challenges
  4. 2.4 High-Throughput Sequencing Technology Industry Restraints
3 High-Throughput Sequencing Technology Market by Company
  1. 3.1 Global High-Throughput Sequencing Technology Company Revenue Ranking in 2025
  2. 3.2 Global High-Throughput Sequencing Technology Revenue by Company (2021-2026)
  3. 3.3 Global High-Throughput Sequencing Technology Company Ranking (2024-2026)
  4. 3.4 Global High-Throughput Sequencing Technology Company Manufacturing Base and Headquarters
  5. 3.5 Global High-Throughput Sequencing Technology Company Product Type and Application
  6. 3.6 Global High-Throughput Sequencing Technology Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global High-Throughput Sequencing Technology Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 High-Throughput Sequencing Technology Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 High-Throughput Sequencing Technology Market by Type
  1. 4.1 High-Throughput Sequencing Technology Type Introduction
  2. 4.1.1 Targeted Sequencing
  3. 4.1.2 Whole Exome Sequencing
  4. 4.1.3 Whole Genome Sequencing
  5. 4.2 Global High-Throughput Sequencing Technology Sales Value by Type
  6. 4.2.1 Global High-Throughput Sequencing Technology Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global High-Throughput Sequencing Technology Sales Value by Type (2021-2032)
  8. 4.2.3 Global High-Throughput Sequencing Technology Sales Value Share by Type (2021-2032)
5 High-Throughput Sequencing Technology Market by Application
  1. 5.1 High-Throughput Sequencing Technology Application Introduction
  2. 5.1.1 Hospitals and Clinics
  3. 5.1.2 Biopharma Companies
  4. 5.1.3 Academic & Research Organizations
  5. 5.1.4 Others
  6. 5.2 Global High-Throughput Sequencing Technology Sales Value by Application
  7. 5.2.1 Global High-Throughput Sequencing Technology Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global High-Throughput Sequencing Technology Sales Value by Application (2021-2032)
  9. 5.2.3 Global High-Throughput Sequencing Technology Sales Value Share by Application (2021-2032)
6 High-Throughput Sequencing Technology Regional Value Analysis
  1. 6.1 Global High-Throughput Sequencing Technology Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global High-Throughput Sequencing Technology Sales Value by Region (2021-2032)
  3. 6.2.1 Global High-Throughput Sequencing Technology Sales Value by Region: 2021-2026
  4. 6.2.2 Global High-Throughput Sequencing Technology Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America High-Throughput Sequencing Technology Sales Value (2021-2032)
  7. 6.3.2 North America High-Throughput Sequencing Technology Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe High-Throughput Sequencing Technology Sales Value (2021-2032)
  10. 6.4.2 Europe High-Throughput Sequencing Technology Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific High-Throughput Sequencing Technology Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific High-Throughput Sequencing Technology Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America High-Throughput Sequencing Technology Sales Value (2021-2032)
  16. 6.6.2 South America High-Throughput Sequencing Technology Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa High-Throughput Sequencing Technology Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa High-Throughput Sequencing Technology Sales Value Share by Country, 2025 VS 2032
7 High-Throughput Sequencing Technology Country-level Value Analysis
  1. 7.1 Global High-Throughput Sequencing Technology Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global High-Throughput Sequencing Technology Sales Value by Country (2021-2032)
  3. 7.2.1 Global High-Throughput Sequencing Technology Sales Value by Country (2021-2026)
  4. 7.2.2 Global High-Throughput Sequencing Technology Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt High-Throughput Sequencing Technology Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt High-Throughput Sequencing Technology Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt High-Throughput Sequencing Technology Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Eurofins Scientific
  2. 8.1.1 Eurofins Scientific Company Information
  3. 8.1.2 Eurofins Scientific Business Overview
  4. 8.1.3 Eurofins Scientific High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eurofins Scientific High-Throughput Sequencing Technology Product Portfolio
  6. 8.1.5 Eurofins Scientific Recent Developments
  7. 8.2 Natera
  8. 8.2.1 Natera Company Information
  9. 8.2.2 Natera Business Overview
  10. 8.2.3 Natera High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Natera High-Throughput Sequencing Technology Product Portfolio
  12. 8.2.5 Natera Recent Developments
  13. 8.3 BGI
  14. 8.3.1 BGI Company Information
  15. 8.3.2 BGI Business Overview
  16. 8.3.3 BGI High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BGI High-Throughput Sequencing Technology Product Portfolio
  18. 8.3.5 BGI Recent Developments
  19. 8.4 Illumina
  20. 8.4.1 Illumina Company Information
  21. 8.4.2 Illumina Business Overview
  22. 8.4.3 Illumina High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Illumina High-Throughput Sequencing Technology Product Portfolio
  24. 8.4.5 Illumina Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche High-Throughput Sequencing Technology Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 LabCorp
  32. 8.6.1 LabCorp Company Information
  33. 8.6.2 LabCorp Business Overview
  34. 8.6.3 LabCorp High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LabCorp High-Throughput Sequencing Technology Product Portfolio
  36. 8.6.5 LabCorp Recent Developments
  37. 8.7 Berry Genomics
  38. 8.7.1 Berry Genomics Company Information
  39. 8.7.2 Berry Genomics Business Overview
  40. 8.7.3 Berry Genomics High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Berry Genomics High-Throughput Sequencing Technology Product Portfolio
  42. 8.7.5 Berry Genomics Recent Developments
  43. 8.8 Brooks Life Sciences
  44. 8.8.1 Brooks Life Sciences Company Information
  45. 8.8.2 Brooks Life Sciences Business Overview
  46. 8.8.3 Brooks Life Sciences High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Brooks Life Sciences High-Throughput Sequencing Technology Product Portfolio
  48. 8.8.5 Brooks Life Sciences Recent Developments
  49. 8.9 Macrogen
  50. 8.9.1 Macrogen Company Information
  51. 8.9.2 Macrogen Business Overview
  52. 8.9.3 Macrogen High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Macrogen High-Throughput Sequencing Technology Product Portfolio
  54. 8.9.5 Macrogen Recent Developments
  55. 8.10 Personalis
  56. 8.10.1 Personalis Company Information
  57. 8.10.2 Personalis Business Overview
  58. 8.10.3 Personalis High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Personalis High-Throughput Sequencing Technology Product Portfolio
  60. 8.10.5 Personalis Recent Developments
  61. 8.11 Novogene
  62. 8.11.1 Novogene Company Information
  63. 8.11.2 Novogene Business Overview
  64. 8.11.3 Novogene High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Novogene High-Throughput Sequencing Technology Product Portfolio
  66. 8.11.5 Novogene Recent Developments
  67. 8.12 Genotypic Technology
  68. 8.12.1 Genotypic Technology Company Information
  69. 8.12.2 Genotypic Technology Business Overview
  70. 8.12.3 Genotypic Technology High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Genotypic Technology High-Throughput Sequencing Technology Product Portfolio
  72. 8.12.5 Genotypic Technology Recent Developments
  73. 8.13 Dna Link
  74. 8.13.1 Dna Link Company Information
  75. 8.13.2 Dna Link Business Overview
  76. 8.13.3 Dna Link High-Throughput Sequencing Technology Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Dna Link High-Throughput Sequencing Technology Product Portfolio
  78. 8.13.5 Dna Link Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research